Researchers Pinpoint Optimal Frequency Using TTFields for Mesothelioma Treatment

Researchers Pinpoint Optimal Frequency Using TTFields for Mesothelioma Treatment

ByAlex Strauss

The makers of TTFields for mesothelioma treatment have released a new report that sheds light on how the therapy can be most effective.  TTFields stands for “Tumor Treating Fields”. It is a device that emits intermediate frequency alternating electrical fields. These fields are designed to disrupt cancer DNA and shrink tumors.  The FDA approved TTFields for mesothelioma treatment in 2019. At the time, it was the first new treatment for this intractable cancer since 2004. It is still the only non-invasive treatment for pleural mesothelioma.  The new report from researchers at Novocure may help doctors use TTFields more effectively for their patients with inoperable mesothelioma. TTFields for Mesothelioma Treatment The Tumor Treating Fields approach was first used to treat glioblastoma….

Keytruda and Tumor Treating Fields: New Hope for Mesothelioma?
| | |

Keytruda and Tumor Treating Fields: New Hope for Mesothelioma?

ByAlex Strauss

There is hope that a new lung cancer trial combining Keytruda and Tumor Treating Fields could lead to a new treatment for pleural mesothelioma.  Recent studies show Keytruda (pembrolizumab) is one of the most promising immunotherapy drugs against malignant mesothelioma. Electrical device Tumor Treating Fields is only the second treatment to receive FDA approval for mesothelioma.  This summer, the manufacturers of these two treatments announced they would team up. They will test Keytruda and Tumor Treating Fields in patients with non-small cell lung cancer. The results could impact the future of mesothelioma treatment, too. Two Promising Therapies: Keytruda Keytruda is an immunotherapy drug. It blocks a protein called PD-1. Many types of cancer cells overproduce PD-1 to evade the immune…

TTFields Treatment for Mesothelioma: Physician Acceptance is Critical
|

TTFields Treatment for Mesothelioma: Physician Acceptance is Critical

ByAlex Strauss

A new article suggests that non-invasive TTFields treatment for mesothelioma has the potential to save lives – as long as enough physicians accept it.  TTFields stands for Tumor Treating Fields. It is an electricity-based treatment approved by the FDA for use along with standard mesothelioma chemotherapy.  Cancer researchers from West Cancer Center and Research Institute wrote the new article for The Oncologist. They say the success of TTFields treatment for mesothelioma depends on doctors learning the logistics of using it.  How Does TTFields Treatment for Mesothelioma Work? TTFields use low-intensity alternating electric fields. When these electric fields hit a mesothelioma tumor, they disrupt normal cell division. If cancer cells cannot divide properly, they are less likely to spread out of…

Tumor Treating Fields Win FDA Approval for Mesothelioma Treatment
|

Tumor Treating Fields Win FDA Approval for Mesothelioma Treatment

ByAlex Strauss

The FDA has approved an electricity-based mesothelioma treatment known as Tumor Treating Fields (NovoTTF-100L). The treatment is approved for use along with standard mesothelioma chemotherapy. It is the first new treatment for pleural mesothelioma since the approval of Alimta (pemetrexed) in 2004. Approval of NovoTTF-100L was based on the promising results of the STELLAR phase 2 mesothelioma clinical trial. Those results, released in April, were even better than expected. Electricity is the Basis of Tumor Treating Fields The Tumor Treating Fields approach was created by Jersey-based Novocure. It first found success in the treatment of the deadly brain cancer glioblastoma. The technology uses electrical fields to destabilize critical proteins responsible for cell division. When these proteins cannot do their job,…